- Orix Corporation’s third-quarter net income reached 88.83 billion yen, a 2.5% decrease compared to the previous year.
- The reported net income fell short of the estimated 91.91 billion yen.
- Net sales rose by 11% year on year to 750.85 billion yen, although this was below the projected 818.19 billion yen.
- For the full year, Orix forecasts a net income of 390.00 billion yen, closely aligning with the estimate of 389.24 billion yen.
- The company maintains its dividend forecast at 98.60 yen, which is below the estimated 133.42 yen.
- Market sentiment on Orix includes 6 buy ratings, 5 hold ratings, and no sell ratings.
A look at Orix Corp Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 2 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Orix Corp shows a positive long-term outlook across various factors. With strong scores in Value, Dividend, and Growth, the company is positioned well for sustained performance. These scores indicate that Orix Corp is considered to have favorable valuation, dividend payment potential, and growth prospects.
However, the company’s scores for Resilience and Momentum are lower, suggesting some challenges in terms of weathering market uncertainties and maintaining upward momentum. Despite this, Orix Corp‘s diverse range of financial services, including leasing, real estate loans, and consumer finance, provide a solid foundation for continued growth. Additionally, the company’s involvement in environment-related and private equity investment businesses offers potential for expansion into new markets and industries. Notably, Orix Corp also has a unique presence in the sports world through its ownership of the ORIX Buffalos professional baseball team.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
